A recently published preprint study adds to the long list of evidence linking Abrysvo, Pfizer’s respiratory syncytial virus (RSV) vaccine for pregnant women, to higher incidences of preterm births. The study, conducted by Canadian researchers at the University of Ottawa School of Epidemiology and Public Health, examined adverse events reported to the Vaccine Adverse Event Reporting System (VAERS), the federal […]

www.naturalnews.com